iZafe Group AB Series B (IZAFE-B) - Cash Flow Conversion Efficiency
Based on the latest financial reports, iZafe Group AB Series B (IZAFE-B) has a cash flow conversion efficiency ratio of -0.190x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Skr-4.65 Million ≈ $-500.74K USD) by net assets (Skr24.47 Million ≈ $2.63 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See net asset quality index of iZafe Group AB Series B to measure how much of total assets are equity-financed.
iZafe Group AB Series B - Cash Flow Conversion Efficiency Trend (2012–2025)
This chart illustrates how iZafe Group AB Series B's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check cash flow quality index of iZafe Group AB Series B to evaluate the quality of earnings relative to operating cash generation.
iZafe Group AB Series B Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of iZafe Group AB Series B ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Thai Packaging & Printing Public Company Limited
BK:TPP
|
0.007x |
|
US Copper Corp
V:USCU
|
-0.153x |
|
Nextplat Corp
NASDAQ:NXPL
|
-0.127x |
|
Taihan Textile
KO:001070
|
-0.044x |
|
Banco Santander Río S.A
BA:BRIO6
|
-0.322x |
|
Nusatama Berkah Tbk PT
JK:NTBK
|
-0.177x |
|
DOTZ Nano Ltd
AU:DTZ
|
0.228x |
|
Sapura Industrial Bhd
KLSE:7811
|
0.278x |
Annual Cash Flow Conversion Efficiency for iZafe Group AB Series B (2012–2025)
The table below shows the annual cash flow conversion efficiency of iZafe Group AB Series B from 2012 to 2025. For the full company profile with market capitalisation and key ratios, see market value of iZafe Group AB Series B.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | Skr11.69 Million ≈ $1.26 Million |
Skr-14.56 Million ≈ $-1.57 Million |
-1.246x | -6.74% |
| 2024-12-31 | Skr9.73 Million ≈ $1.05 Million |
Skr-11.36 Million ≈ $-1.22 Million |
-1.167x | -162.91% |
| 2023-12-31 | Skr25.35 Million ≈ $2.73 Million |
Skr-11.26 Million ≈ $-1.21 Million |
-0.444x | +19.39% |
| 2022-12-31 | Skr38.96 Million ≈ $4.19 Million |
Skr-21.46 Million ≈ $-2.31 Million |
-0.551x | +33.02% |
| 2021-12-31 | Skr40.73 Million ≈ $4.38 Million |
Skr-33.49 Million ≈ $-3.60 Million |
-0.822x | +1.40% |
| 2020-12-31 | Skr29.46 Million ≈ $3.17 Million |
Skr-24.57 Million ≈ $-2.64 Million |
-0.834x | -100.85% |
| 2019-12-31 | Skr36.89 Million ≈ $3.97 Million |
Skr-15.32 Million ≈ $-1.65 Million |
-0.415x | -197.93% |
| 2018-12-31 | Skr10.12 Million ≈ $1.09 Million |
Skr-1.41 Million ≈ $-151.74K |
-0.139x | +58.08% |
| 2017-12-31 | Skr11.19 Million ≈ $1.20 Million |
Skr-3.72 Million ≈ $-400.22K |
-0.332x | +58.28% |
| 2016-12-31 | Skr5.42 Million ≈ $582.96K |
Skr-4.32 Million ≈ $-464.47K |
-0.797x | -292.09% |
| 2015-12-31 | Skr8.72 Million ≈ $938.85K |
Skr-1.77 Million ≈ $-190.78K |
-0.203x | -121.50% |
| 2014-12-31 | Skr9.04 Million ≈ $973.08K |
Skr-829.55K ≈ $-89.27K |
-0.092x | -13.91% |
| 2013-12-31 | Skr11.69 Million ≈ $1.26 Million |
Skr-941.32K ≈ $-101.30K |
-0.081x | +6.07% |
| 2012-12-31 | Skr18.92 Million ≈ $2.04 Million |
Skr-1.62 Million ≈ $-174.55K |
-0.086x | -- |
About iZafe Group AB Series B
iZafe Group AB (publ), a medical technology company, engages in the research, development, and marketing of digital medical solutions and services for safer drug management at home. The company provides Dosell, an automated medication dispenser that handles medication pouches, smart pillboxes, facilitates and enables independent medication, and reminds and alerts in the scheduled doses. It also o… Read more